Correction to: Fuzuloparib: First Approval.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Works matching IS 00126667 AND DT 2021 AND VI 81 AND IP 13
Results: 10
1
2
Cefiderocol: A Review in Serious Gram-Negative Bacterial Infections.
- Published in:
- Drugs, 2021, v. 81, n. 13, p. 1559, doi. 10.1007/s40265-021-01580-4
- By:
- Publication type:
- Article
3
Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain.
- Published in:
- Drugs, 2021, v. 81, n. 13, p. 1513, doi. 10.1007/s40265-021-01579-x
- By:
- Publication type:
- Article
4
Upacicalcet: First Approval.
- Published in:
- Drugs, 2021, v. 81, n. 13, p. 1593, doi. 10.1007/s40265-021-01578-y
- By:
- Publication type:
- Article
5
Contezolid: First Approval.
- Published in:
- Drugs, 2021, v. 81, n. 13, p. 1587, doi. 10.1007/s40265-021-01576-0
- By:
- Publication type:
- Article
6
Hetrombopag: First Approval.
- Published in:
- Drugs, 2021, v. 81, n. 13, p. 1581, doi. 10.1007/s40265-021-01575-1
- By:
- Publication type:
- Article
7
Sotorasib: First Approval.
- Published in:
- Drugs, 2021, v. 81, n. 13, p. 1573, doi. 10.1007/s40265-021-01574-2
- By:
- Publication type:
- Article
8
A Role for SGLT-2 Inhibitors in Treating Non-diabetic Chronic Kidney Disease.
- Published in:
- Drugs, 2021, v. 81, n. 13, p. 1491, doi. 10.1007/s40265-021-01573-3
- By:
- Publication type:
- Article
9
The Potential Role of Clinical Metagenomics in Infectious Diseases: Therapeutic Perspectives.
- Published in:
- Drugs, 2021, v. 81, n. 13, p. 1453, doi. 10.1007/s40265-021-01572-4
- By:
- Publication type:
- Article
10
Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies.
- Published in:
- Drugs, 2021, v. 81, n. 13, p. 1467, doi. 10.1007/s40265-021-01555-5
- By:
- Publication type:
- Article